cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Travere Therapeutics Inc
7 own
1 watching
Current Price
$6.56
$-0.05
(-0.76%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
685.99M
52-Week High
52-Week High
19.54240
52-Week Low
52-Week Low
5.12000
Average Volume
Average Volume
0.79M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
59.2089
iconMarket Capitalization685.99M
icon52-Week High19.54240
icon52-Week Low5.12000
iconAverage Volume0.79M
iconDividend Yield--
iconP/E Ratio59.2089
What does the Travere Therapeutics Inc do?
Travere Therapeutics Inc, a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in well-opacifying gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for adjunctive treatment of patients with peroxisomal disorders; and Thiola, a tiopronin tablet for the treatment of cystinuria. The company's product candidates consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis; Fosmetpantotenate, a novel small molecule that is in Phase III clinical trial to treat pantothenate kinase-associated neurodegeneration; Tetracosactide Zinc (RE-034), a synthetic hormone analog that is in preclinical stage; and Liquid Ursodeoxycholic Acid, a liquid formulation of ursodeoxycholic acid, which is in preclinical stage to treat primary biliary cholangitis. Retrophin, Inc. was founded in 2011 and is headquartered in San Diego, California.
Read More
How much money does Travere Therapeutics Inc make?
News & Events about Travere Therapeutics Inc.
PR Newswire
10 months ago
TVTX ALERT: The Law Offices of Vincent Wong Investigate Travere Therapeutics, Inc. for Potential Violations of Securities Laws TVTX ALERT: The Law Offices of Vincent Wong Investigate Travere Therapeutics, Inc. for Potential Violations of Securities Laws PR Newswire NEW YORK, July 3, 2023 NEW YORK...
PR Newswire
10 months ago
TVTX FRAUD ALERT: Jakubowitz Law is Investigating Travere Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws TVTX FRAUD ALERT: Jakubowitz Law is Investigating...
PR Newswire
11 months ago
TVTX FRAUD ALERT: Jakubowitz Law is Investigating Travere Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws TVTX FRAUD ALERT: Jakubowitz Law is Investigating Travere Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws PR Newswire...
PR Newswire
11 months ago
TVTX INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Travere Therapeutics, Inc. TVTX INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities...
Ticker Report
11 months ago
Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX Get Rating) have earned an average recommendation of Moderate Buy from the thirteen analysts that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and ...
Frequently Asked Questions
Frequently Asked Questions
What is Travere Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Travere Therapeutics Inc shares?
plus_minus_icon
How can I buy Travere Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Travere Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Travere Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Travere Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Travere Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Travere Therapeutics Inc?
plus_minus_icon
What percentage is Travere Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Travere Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$6.56
$-0.05
(-0.76%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00